Less document rework
Standard templates, controlled workflows, and digital execution reduce repeated manual corrections and version conflicts.
Estimate annual time savings, FTE hours freed, and direct cost reductions when transitioning your team from legacy CSV to a digital, FDA CSA-aligned validation lifecycle management platform.
Move the sliders to match your current process. Your savings estimate updates instantly.
Adjust the values to fit your organisation.
The calculator applies a 57% cycle-time reduction and 50% active effort fraction benchmarked from GoVal customer outcomes. Annual savings = validations × cycle days × active effort fraction × avg people × day rate × 57%. Actual savings depend on validation complexity, site count, approval depth, and adoption speed.
GoVal eliminates the manual overhead hidden inside every validation cycle: document preparation, review routing, traceability maintenance, signature delays, version control, and audit-readiness effort.
Book a 30-min DemoStandard templates, controlled workflows, and digital execution reduce repeated manual corrections and version conflicts.
21 CFR Part 11-compliant e-signatures and parallel review routing eliminate 2–5 day signature delays per document cycle.
URS, risk assessments, test scripts, deviations, and approvals stay linked through a live, auto-updating RTM.
Validation records are complete, indexed, and retrievable in seconds — eliminating 3–5 day audit-prep windows.
GoVal users typically save up to 57% of cycle time per validation and reduce FTE documentation effort by 30–50%. For a team running 50 validations per year at a $750/day loaded rate with 3 people per validation, annual direct savings commonly exceed $480,000. Use the calculator above for a personalised figure.
ROI comes from three areas: cycle-time reduction (40–57%), lower FTE effort on documentation, and reduced audit-remediation costs. GoVal customers typically see full payback within 12–18 months of go-live, with some achieving it in under 14 months.
GoVal provides standardised templates, controlled digital workflows, e-signature routing, and a live auto-updating RTM. These eliminate manual document chasing, version-control errors, and signature delays common in paper-based validation programmes.
Yes. GoVal is purpose-built for GxP-regulated validation teams. It natively supports 21 CFR Part 11 electronic records and e-signatures, EU Annex 11, and FDA CSA guidance. All records are audit-trail–protected and continuously inspection-ready.
GoVal deploys in under six weeks from contract signature to live production use. It ships pre-validated with IQ/OQ/PQ documentation included, so customers skip the pre-implementation CSV project required by most platforms.
The calculator uses industry-validated benchmarks from GoVal customer data: 57% cycle-time reduction and 50% active effort fraction per validation. Results are directionally accurate for most life sciences validation programmes. For a bespoke analysis, GoVal consultants can model savings against your specific validation programme and site structure.
Get a tailored ROI breakdown based on your system count, validation process, site structure, and approval workflow.